You are here

Presidio

Shares Of BioCryst Pop On Merger Termination, But Gains Are Temporary

Seeking Alpha

Fri, 11/30/12 - 04:02 pm

BioCryst, Presidio Merger Creates Yet Another Competitor in the HCV Segment

Yahoo/Fly on the Wall

Thu, 10/18/12 - 01:10 pm

Presidio Pharmaceuticals Announces a New Clinical Candidate, PPI-383, a Novel Pan-Genotypic Non-Nucleoside Polymerase Inhibitor for HCV

Pipeline Review

Sun, 04/22/12 - 12:25 pm

Presidio Pharmaceuticals, Inc. to Present Data on their Lead Hepatitis C Virus NS5A Inhibitor Program

Pharma Live

Sat, 04/18/09 - 11:18 am